Epitalon
Symbol Ep · MW 390 Da
Short tetrapeptide studied for telomerase activation and circadian regulation.
- Discovered
- 1998
- Half-life
- Unknown
- Approval
- Not FDA-approved
Quick facts
- Category
- Longevity
- Route
- Injectable
- Molecular weight
- 390 Da
- Half-life
- Unknown
- Discovered
- 1998
- Approval status
- Not FDA-approved
Reported effects
- Telomere support
- Sleep cycles
- Anti-aging research
Overview
Epithalon, also known as Epitalon, is a short synthetic peptide commonly discussed in longevity, anti-aging, and cellular health research. It is often associated with telomere biology, circadian rhythm support, pineal gland function, and age-related cellular processes. Epithalon is frequently marketed as a longevity peptide because of its connection to aging pathways and cellular repair theories. Its purpose is to support healthy aging research, sleep-wake regulation, and long-term cellular function. While it is popular in the anti-aging peptide space, many claims require more human clinical evidence, so it is best described as a longevity research peptide rather than a proven life-extension treatment.
Evidence context
Epitalon evidence summary
Human clinical evidence
Epitalon has an approval context listed in the Peptidic database. Approved use still depends on the specific indication, formulation, labeling, and clinician guidance.
Animal, preclinical, or formulation evidence
Epitalon may be discussed in animal, preclinical, in vitro, or early-stage research contexts. Those evidence types are useful for orientation but should not be treated as equivalent to approved human indications.
Status and evidence strength
Peptidic lists the approval status for Epitalon as Not FDA-approved. The reported effects below are reference fields from the peptide database, not medical promises. Source links are included later on the page when available so readers can continue review from primary or reputable sources.
How it's taken
- Typical Administration
- Injectable / Oral / Nasal
- Typical Dosage
- No established approved dosage; commonly referenced cycle range is 5–20 mg daily
- Typical Frequency
- Once daily during short cycles, commonly 10–20 days
Dosing depends on the approved indication, formulation, titration schedule, and clinician guidance. This page is educational and not a substitute for medical advice.
Research sources
Source links included from peer-reviewed literature, clinical records, and medical databases for educational research context on Epitalon.
Internal links
Related peptides
Frequently asked questions
What category is Epitalon in?
Epitalon is listed in the Longevity category on Peptidic.
What route is Epitalon associated with?
Epitalon is associated with the injectable route in the Peptidic database. This is descriptive route context, not a use instruction.
Is Epitalon approved?
Peptidic lists the approval status for Epitalon as: Not FDA-approved. Approval details can vary by indication and jurisdiction.
Interested in Epitalon?
Enter your email and we'll send our recommended peptide vendor for educational research reference.
Review the peptide vendor research checklistEducational reference only · No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions. Explore the full peptide database, peptide calculator, or peptide tracker.
Last reviewed for educational accuracy: 2026-06-01